FDA Establishes Co-development Framework for Investigational New Drugs

Summary

The US Food and Drug Administration (FDA) is launching a new initiative to facilitate co-development of investigational drugs with pharmaceutical companies, aiming to accelerate the development and approval process for new treatments.